New and soon-to-be introduced antimicrobials are reviewed and compared with agents already in use to determine possible therapeutic and/or cost advantages. Drugs discussed are amdinocillin, ticarcillin/clavulanic acid, ceftrixone, ceftazidime, imipenem/cilastatin, aztreonam, and quinolones.
CornettJBWagnerRBDobsonRAIn vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin). Antimicrob Agents Chemother1985; 27: 4–10.
2.
Del RioMAChraneDSheltonSCeftriaxone vs. ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet1983; 1: 1241–4.
3.
HarrisonCJWelchDMarksMI. Ceftriaxone therapy in pediatric patients. Am J Dis Child1983; 137: 1048–51.
4.
HenryDSkidmoreAGNgui-YenJIn vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents. Antimicrob Agents Chemother1985; 28: 259–64.
5.
HöffkenGLodeHPrinzingCPharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother1985; 27: 375–9.
6.
NeuHC. Amdinocillin: a novel penicillin. Pharmacotherapy1985; 5: 1–10.
7.
NeuHC. Aztreonam: a monocyclic beta-lactam antibiotic. Am J Med1985; 87: 1–80.
8.
RamirezCABranJLMejiaCROpen, prospective study of the clinical efficacy of ciprofloxacin. Antimicrob Agents Chemother1985; 28: 28–32.
9.
RemingtonJS. Carbapenems: a new class of antibiotics. Am J Med1985; 78: 1–167.
10.
RichardsDMHeelRCBrogdenRNCeftriaxone: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs1984; 27: 469–527.
11.
RoselleGABodeRHamiltonBClinical trial of the efficacy and safety of ticarcillin and clavulanic acid. Antimicrob Agents Chemother1985; 27: 291–6.
12.
YostRLRamphalR. Ceftazidime review. Drug Intell Clin Pharm1985; 19: 509–13.
